Dopamine News and Research

Latest Dopamine News and Research

Smartphone users have more headaches, find less relief from the medication

A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.

4 Mar 2020

Antidepressant shows promise in helping men with recurrent prostate cancer

An antidepressant in use for decades, repurposed to fight prostate cancer, shows promise in helping patients whose disease has returned following surgery or radiation, a pilot study at USC shows.

4 Mar 2020

Experimental drug offers hope for improving movement symptoms of Parkinson's

Results from a study looking at an experimental drug to tackle the debilitating side effect of dyskinesia, have offered hope that it may have potential as a future treatment for people with Parkinson's.

2 Mar 2020

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Global engineering technologies company, Renishaw, announces that its award-winning intraparenchymal drug delivery device, has played a critical role in a joint Phase 1-2 clinical study with Herantis Pharma plc, for the investigation of cerebral dopamine neurotrophic factor (CDNF)as a treatment for Parkinson's disease.

27 Feb 2020

Renishaw Announces Completion of the Main Part of a Multi-Centre Clinical Trial Jointly Undertaken with Herantis Pharma plc for the Treatment of Parkinson’s Disease Patients

Renishaw, announces that its drug delivery device has played a critical role in the investigation CDNF as a treatment for Parkinson's disease.

From Renishaw plc - Additive Manufacturing for Healthcare Applications 26 Feb 2020

Promising molecule could stop or slow Parkinson’s

A promising molecule has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.

14 Feb 2020

New study may lead to better treatments for Parkinson's disease

Parkinson's disease is a long-term (chronic) neurological condition that affects around 12,000 people in Ireland and between 7 and 10 million people worldwide. The disease affects the way the brain co-ordinates body movements like walking and talking, but cognitive abilities are also affected.

13 Feb 2020

Light-activated protein restores mitochondrion function in fruit fly model of Parkinson’s disease

A light-sensitive protein can restore mitochondria function in fruit flies bearing a gene mutation associated with Parkinson’s disease and relieve its symptoms, report researchers at Juntendo University in the journal Communications Biology.

13 Feb 2020

Researchers identify involvement of certain cortical areas in the loss of control over food intake

Researchers at UPF, in collaboration with researchers from the University of Mainz (Germany), the Center for Genomic Regulation, Instituto Cajal, Johannes Gutenberg University (Germany), the Autonomous University Barcelona and Hospital del Mar have identified for the first time the involvement of certain cortical areas in the brain in the loss of control over food intake.

9 Feb 2020

Making it all work: brain-dependent immune activation in embryos

How does the immune system develop its functionality? This has been an ongoing area of research for biologists. Now, a new study published in the journal NPJ Regenerative Medicine in February 2020 shows that in very early fetal life the brain must signal directions to the developing immune system to help it defend the body from infectious agents. This signaling markedly improves the capability of the embryo to survive when faced with bacterial infection.

4 Feb 2020

Scientists shed new light on neuronal circuits that acquire and update voluntary actions

Two types of neuronal circuit in the brain that acquire and update voluntary actions are much more intertwined than previously thought.

3 Feb 2020

Study suggests prenatal origin for ‘young’ Parkinson’s disease

A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson’s disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.

27 Jan 2020

Parkinson's disease may affect brain cells before birth

People who develop Parkinson's disease before age 50 may have been born with disordered brain cells that went undetected for decades, according to new Cedars-Sinai research. The research points to a drug that potentially might help correct these disease processes.

27 Jan 2020

Potential Parkinson's treatment effectively targets a specific group of brain cells

Scientists have discovered that a non-invasive technique which could one day be used to treat Parkinson's disease, can successfully target a highly specific group of brain cells which play a key role in development of the condition.

22 Jan 2020

Gut microbiome linked to behavioral problems in children

Children with behavioral problems may have different compositions in their gut microbiome, with parents playing a major role in how pronounced the differences were, other than the food they provide, a new study suggests.

21 Jan 2020

New analysis method shows how the brain regulates its signals using glutamate

Researchers at Chalmers University of Technology and Gothenburg University in Sweden have achieved something long thought almost impossible - counting the molecules of the neurotransmitter glutamate released when a signal is transferred between two brain cells. With a new analysis method, they showed that the brain regulates its signals using glutamate in more ways than previously realised.

21 Jan 2020

Researchers identify how certain areas of the brain respond to ADHD drug

Attention-deficit hyperactivity disorder is a neurobiological disorder characterized by symptoms of hyperactivity, inattention and impulsivity.

17 Jan 2020

Researchers find potential new target for treating drug addiction

New University of Minnesota Medical School research discovers a novel potential target for treating drug addiction through "the hidden stars of the brain."

16 Jan 2020

Parkinson’s disease could be prevented by gut microbes

One common gut organism that helps us digest food better could also be a powerful instrument in preventing or reversing the symptoms of Parkinson’s disease (PD), according to a recent study. The changes are due to the ability of this bacterium to delay the build-up of a toxic protein involved in this in the disease condition, or even to eliminate the toxin altogether.

14 Jan 2020

Sugar intake influences brain reward circuitry

The idea of food addiction is a very controversial topic among scientists. Researchers from Aarhus University have delved into this topic and examined what happens in the brains of pigs when they drink sugar water. The conclusion is clear: sugar influences brain reward circuitry in ways similar to those observed when addictive drugs are consumed.

14 Jan 2020

Dopamine News and Research

Latest Dopamine News and Research

Smartphone users have more headaches, find less relief from the medication

Antidepressant shows promise in helping men with recurrent prostate cancer

Experimental drug offers hope for improving movement symptoms of Parkinson's

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Renishaw Announces Completion of the Main Part of a Multi-Centre Clinical Trial Jointly Undertaken with Herantis Pharma plc for the Treatment of Parkinson’s Disease Patients

Promising molecule could stop or slow Parkinson’s

New study may lead to better treatments for Parkinson's disease

Light-activated protein restores mitochondrion function in fruit fly model of Parkinson’s disease

Researchers identify involvement of certain cortical areas in the loss of control over food intake

Making it all work: brain-dependent immune activation in embryos

Scientists shed new light on neuronal circuits that acquire and update voluntary actions

Study suggests prenatal origin for ‘young’ Parkinson’s disease

Parkinson's disease may affect brain cells before birth

Potential Parkinson's treatment effectively targets a specific group of brain cells

Gut microbiome linked to behavioral problems in children

New analysis method shows how the brain regulates its signals using glutamate

Researchers identify how certain areas of the brain respond to ADHD drug

Researchers find potential new target for treating drug addiction

Parkinson’s disease could be prevented by gut microbes

Sugar intake influences brain reward circuitry

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Dopamine News and Research

Latest Dopamine News and Research

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Newsletters you may be interested in